Understanding the metabolic fate of compounds is a requirement for safe pharmaceutical development. Whether supporting early-stage drug discovery, conducting impurity qualification for generics, or preparing data for regulatory submissions, scientists require transparent, scientifically credible predictions aligned with global guidance.
As a member-driven and not-for-profit organisation, we have developed Meteor to meet these needs. Our relaunch of Meteor provides an intuitive decision-support tool for metabolite identification (MetID) and metabolite toxicity assessment, aiding expert human review.
Tailored support across the product lifecycle
Meteor provides support across different scientific sectors:
Drug discovery: Rapid in silico screening helps de-risk candidates early, improving clinical trial success rates and reducing development failures. Updated batch processing and an expanded database allow for faster assessment of chemical libraries.
By identifying “metabolic soft spots” before a compound is even synthesised, you avoid the high cost of late-stage failures. Historically, ADME (absorption, distribution, metabolism, and excretion) and toxicity issues accounted for drug failures; the routine use of in silico tools has helped reduce this saving companies in failed clinical trials.
Computational toxicology & ADME: A redesigned interface with mass filtering and duplicate-route comparison assists in interpreting complex predictions to support experimental structure elucidation. Integration with Derek Nexus allows toxicity endpoints to be evaluated early.
Mass spectrometry (MS) can detect metabolites at trace levels; difficulty can lie in data interpretation. Meteor can help you quickly identify your unknown structures, reducing the time spent on manual structure elucidation from weeks to days.
Regulatory affairs: Meteor provides the transparent reasoning, mechanistic evidence, and referenced biotransformation pathways necessary for ICH M7 and ICH Q3A/B metabolite justification.
Regulatory approval depends on clear defensible evidence. If an impurity is also a significant metabolite, it is “generally considered qualified” under ICH Q3A/B. Meteor helps you validate this, potentially bypassing the need for expensive and time-consuming toxicity studies.
While our software supports a wide range of needs across the drug discovery workflow, two common challenges scientists face when studying metabolism are: improving the speed of metabolite identification and automating the early identification of toxicity.
Use case 1: Use Case 1: Improving the speed of Metabolite Identification (MetID)
Our solution improves how you manage your data:
- Mass filtering: enables comparison with MS data for rapid interpretation of metabolite peaks.
- Duplicate filtering: reveals all possible metabolic routes to a single observed metabolite, assisting experimental elucidation.
- Updated knowledge-base: ensures metabolic pathways reflect current scientific understanding, including nitrosamine transformations.
Together, these features help us reduce your manual review efforts and support clearer, faster decision-making.
Use case 2: Use Case 2: Early Identification of Metabolite Toxicity
Through integration with our Derek Nexus solution, Meteor supports a weight-of-evidence approach for assessing predicted metabolite structures:
- Identify relevant metabolites: You can quickly identify which predicted metabolites require further toxicological evaluation.
- Support regulatory compliance: Our combined workflow helps organisations meet ICH M7 expectations for assessing potential mutagenic impurities.
- Provide scientific justification: Biotransformation literature evidence and mechanistic predictions support confident risk-assessments.
This connected workflow ultimately supports a more evidence-based risk assessment.
Conclusion
Across the pharmaceutical industry, organisations seek more efficient ways to integrate in silico prediction with experimental workflows. The expanded features, transparency, and user‑centric improvements in Meteor provide support with:
- Faster MetID
- Toxicity flagging
- Regulatory justification
By enabling faster interpretation and stronger scientific justification, Meteor is well‑positioned to support both discovery-stage innovation and regulatory‑aligned safety assessment.
Want to see Meteor in action? Book a personalised demonstration and free trial with our team.
Last Updated on March 16, 2026 by lhasalimited
